Advertisement

Positron Emission Tomography: Current Achievements and Future Projections

  • Dean F. Wong
Part of the Medical Radiology book series (MEDRAD)

Abstract

Positron emission tomography (PET) scanning has often been proposed as a basic research tool on the one hand and as a potential clinical imaging modality on the other hand. PET can provide important information about basic physiological mechanisms and identify possible biological markers of disease. There are many future applications, including measurement of biological parameters and therapeutic monitoring of drugs.

Keywords

Positron Emission Tomography Single Photon Emission Compute Tomography Myocardial Blood Flow Positron Emission Tomography Study Receptor Occupancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackermann RF, Finch DM, Babb TL et al. (1982) Increased glucose metabolism during long-duration recurrent inhibition of hippocampal pyramidal cells. J Neuroscience 4: 251–264Google Scholar
  2. Alpert NM, Ackerman RH, Correia JA et al. (1977) Measurement of rCBF and rCMRO2 by continuous inhalation of 15O-labeled CO2 and O2. Acta Neurol Scand 56 (Suppl 72): 186–187Google Scholar
  3. Beller GA, Cochavi S, Smith TW et al. (1982) Positron emission tomographic imaging of the myocardium with 81Rb. J Comput Assist Tomogr 6: 341–349PubMedCrossRefGoogle Scholar
  4. Bergstrom M, Collins VP, Ehrin E et al. (1983) Discrepancies in brain tumor extent as shown by computer tomography and positron emission tomography using [68Ga] EDTA, [11C] glucose and [11] methionine. J Comput Assist Tomogr 7: 1062–1066PubMedCrossRefGoogle Scholar
  5. Bergstrom M, Mosskin M, Ericson K et al. (1985) Accumulation kinetics of 11D-D-glucose, (methyl-11C)-L-methionine and 68Ga-EDTA in brain tumors measured with positron emission tomography. In : Lilja A (ed) Radiological aspects of the diagnosis of supratentorial gliomas. Uppsala University, pp 2–17Google Scholar
  6. Bice AN, Wong DF, Wagner HN Jr (1987) On estimating the loss of quantification in PET due to finite detector resolution. Eur J Nucl Med 13: 1–6PubMedCrossRefGoogle Scholar
  7. Brudin LH, Rhodes CG, Valind SO et al. (1987) Regional lung density and blood volume in nonsmoking and smoking subjects measured by PET. J Appl Physiol 63: 1324–1334PubMedGoogle Scholar
  8. Budinger TF, Derenzo SE, Huesman RH et al. (1981) Quantitative myocardial flow extraction data using gated ECT (abstract). J Nucl Med 21: P16Google Scholar
  9. Celesia G, Polcyn R, Holden J et al. (1983) 18-F-fluoromethane positron emission tomography determination of regional cerebral blood flow in cerebral infarction. J Cereb Blood Flow Metab 3 (Suppl 1): 523–524Google Scholar
  10. Chugani HT, Phelps ME (1986) Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science 231: 840–843PubMedCrossRefGoogle Scholar
  11. Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol 4: 487–497CrossRefGoogle Scholar
  12. Collins RC (1978 a) Kindling of neuroanatomic pathways during recurrent focal penicillin seizures. Brain Res 150: 503–518PubMedCrossRefGoogle Scholar
  13. Collins RC (1978 b) Use of cortical circuits during focal penicillin seizures: An autoradiographic study with 14C-deoxyglucose. Brain Res 150: 487–502PubMedCrossRefGoogle Scholar
  14. Dichiro G, DeLaPaz RL, Brooks RA et al. (1982) Glucose utilization of cerebral gliomas measured by [18F]fluorode-oxyglucose and positron emission tomography. Neurology 32:1323–1329Google Scholar
  15. Engel J Jr, Kuhl DE, Phelps ME (1982 a) Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 218: 64–66PubMedCrossRefGoogle Scholar
  16. Engel J Jr, Kuhl DE, Phelps ME et al. (1982b) Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 33: 400–413Google Scholar
  17. Evans AC, Beil C, Marrett S et al. (1988) Anatomical-functional correlation using an adjustable MRI-based region of interest atlas with positron emission tomography. J Cereb Blood Flow Metab 8: 255CrossRefGoogle Scholar
  18. Farde L, Hall H, Ehrin E et al. (1986) Quantitative analysis of dopamine D2 dopamine receptor binding in the living brain by PET. Science 231: 258–261PubMedCrossRefGoogle Scholar
  19. Fox PT, Perlmutter JS, Raichle ME (1985) A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr 9: 141–153PubMedCrossRefGoogle Scholar
  20. Fox PT, Mintun MA, Raichle ME et al. (1986) Mapping human visual cortex with positron emission tomography. Nature 323: 806–809PubMedCrossRefGoogle Scholar
  21. Fox PT, Raichle ME, Mintun MA et al. (1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241: 462–464PubMedCrossRefGoogle Scholar
  22. Frackowiak RS, Lenzi G, Jones T et al. (1980) Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: Theory, procedure, and normal values. J Comput Assist Tomogr 4: 727–736PubMedCrossRefGoogle Scholar
  23. Garnett ES, Firnau G, Nahmias C (1983) Dopamine visualized in the basal ganglia of living man. Nature 305: 137–138PubMedCrossRefGoogle Scholar
  24. Hawkins RA, Phelps ME, Huang SC et al. (1981) Effect of ischemia on quantification of local cerebral glucose metabolic rate in man. J Cereb Blood Flow Metab 1: 37–51PubMedCrossRefGoogle Scholar
  25. Hawkins RA, Phelps ME, Huang SC (1986) Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: Studies in human brain tumors with PET. J Cereb Blood Flow Metab 6: 170–183PubMedCrossRefGoogle Scholar
  26. Hayden MR, Hewitt J, Stossl AJ et al. (1987) The combined use of positron emission tomography and DNA polymorphysms for preclinical detection of Huntington’s disease. Neurology 37: 1441 PubMedGoogle Scholar
  27. Hnatowich DJ (1976) Labeling of human albumin microspheres with Ga-68. J Nucl Med 17: 57–60PubMedGoogle Scholar
  28. Hoyer S (1982) Normal and abnormal circulation and oxidative metabolism in the aging human brain. J Cereb Blood Flow Metab 2 (Suppl 1): 510–513Google Scholar
  29. Huang SC, Phelps ME, Hoffman EJ et al. (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238: E69–E82PubMedGoogle Scholar
  30. Huang SC, Phelps ME, Hoffman EJ et al. (1981) Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose. J Cereb Blood Flow Metab 1:391–401PubMedCrossRefGoogle Scholar
  31. Hughes JM, Brudin LH, Valind SO et al. (1987) Positron emission tomography in the lung. J Thorac Imaging 1: 79–88CrossRefGoogle Scholar
  32. Ito M, Lammertsma AA, Wise RJ et al. (1982) Measurement of regional cerebral blood flow and oxygen utilization in patients with cerebral tumors using 15 and positron emission tomography: Analytical techniques and preliminary results. Neuroradiology 23: 63–74PubMedCrossRefGoogle Scholar
  33. Kuhl DE, Phelps ME, Kowell AP et al. (1980) Mapping local metabolism and perfusion in normal and ischemic brain by emission computed tomography of 18FDG and 13NH3. Ann Neurol 8: 47–60PubMedCrossRefGoogle Scholar
  34. Kuhl DE, Metter EJ, Riege WH et al. (1982 a) Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F] fluorodeoxyglucose method. J Cereb Blood Flow Metab 2: 163–171PubMedCrossRefGoogle Scholar
  35. Kuhl DE, Phelps ME, Markham M et al. (1982 b) Cerebral metabolism and atrophy in Huntington’s disease determined by 18FDG and computed tomographic scan. Ann Neurol 12:425PubMedCrossRefGoogle Scholar
  36. Kummer F (1987) Nuclear medicine in diseases of the lung -present status and future. Introduction — clinical aspects. Eur J Nucl Med 13 (Suppl): 2–5CrossRefGoogle Scholar
  37. LaFrance ND, Tuama L, Villemagne V et al. (1987) Quantitative imaging and follow-up experience of C-11-L-methionine accumulation in brain tumors with positron emission tomography. J Nucl Med 28: 645Google Scholar
  38. Leenders KL, Poewe WH, Palmer AJ et al. (1986) Inhibition of L-[18F] fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Ann Neurol 20: 258PubMedCrossRefGoogle Scholar
  39. Lenzi GL, Frackowiak RS, Jones T et al (1981) CMRO2 and CBF by the oxygen-15 inhalation techniques: Results in normal volunteers and cerebrovascular patients. Eur Neurol 20: 285–290PubMedCrossRefGoogle Scholar
  40. Lenzi GL, Frackowiak RS, Jones T (1982) Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab 2: 321:335PubMedCrossRefGoogle Scholar
  41. Lever SZ, Burns HD, Kervitsky TM et al. (1985) Design, preparation, and biodistribution of a technetium-99-m triaminedithiol complex to assess regional cerebral blood flow. J Nucl Med 26: 1287–1294PubMedGoogle Scholar
  42. Marchai G, Evans A, Dagher A et al. (1987) The evolution of cerebral infarction with time: A PET study of the ischemic penumbra. J Cereb Blood Flow Metab 7 (Suppl): 599CrossRefGoogle Scholar
  43. Marshall RC, Tillisch JH, Phelps ME et al. (1983) Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 67: 766–778PubMedCrossRefGoogle Scholar
  44. Mazziotta JC, Phelps ME, Carson PE et al. (1982) Tomographic mapping of human cerebral metabolism : auditory stimulation. Neurology 32: 921–937PubMedGoogle Scholar
  45. Mazziotta JC, Phelps ME, Halgren E (1983) Local cerebral glucose metabolic response to audiovisual stimulation and deprivation: Studies in human subjects with positron CT. Human Neurobiol 2: 11–23Google Scholar
  46. Mazziotta JC, Phelps ME, Pahl JJ et al. (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington’s disease. N Engl J Med 316: 357PubMedCrossRefGoogle Scholar
  47. Mintun MA, Ter-Pogossian MM, Green MA et al. (1986) Quantitative measurement of regional pulmonary blood flow with positron emission tomography. J Appl Physiol 60:317–326PubMedGoogle Scholar
  48. Mintun MA, Dennis DR, Welch MJ et al. (1987) Measurements of pulmonary vascular permeability with PET and gallium-68 transferrin. J Nucl Med 28: 1704–1716PubMedGoogle Scholar
  49. Nolop KB, Rhodes CG, Brudin LH et al. (1987) Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60: 2682–2689PubMedCrossRefGoogle Scholar
  50. Posner MI, Petersen SE, Fox PT et al. (1988) Localization of cognitive operations in the human brain. Science 240: 1627–1631PubMedCrossRefGoogle Scholar
  51. Schelbert HR, Phelps ME, Hoffman EJ et al. (1979) Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 43: 209–218PubMedCrossRefGoogle Scholar
  52. Schelbert HR, Henze E, Phelps ME (1980) Emission tomography of the heart. Semin Nucl Med 10: 355PubMedCrossRefGoogle Scholar
  53. Schuster DP, Marklin GF (1986) Effect of changes in inflation and blood volume on regional lung density — a PET study: 2. J Comput Assist Tomogr 10: 730–735PubMedCrossRefGoogle Scholar
  54. Schuster DP, Mintun MA (1987) Pulmonary circulation, extravascular water, and solute flux as determined by positron emission tomography. Lymphology 20: 25–35PubMedGoogle Scholar
  55. Schuster DP, Marklin GF, Mintun MA et al. (1986) PET measurement of regional lung density: 1. J Comput Assist Tomogr 10: 723–729PubMedCrossRefGoogle Scholar
  56. Schwaiger M, Huang SC, Krivokapich J et al. (1983) Myocardial glucose utilization measured noninvasively in man by positron tomography (abstract). J Am Coll Cardiol I: 688Google Scholar
  57. Schwaiger M, Brunken RC, Grover M et al. (1984) Regional metabolism in patients with acute myocardial infarction determined by positron tomography (PET) (abstract). Circulation 70 (Suppl II): 249Google Scholar
  58. Schwaiger M, Brunken R, Grover-McKay M et al. (1986) Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 8: 800–808PubMedCrossRefGoogle Scholar
  59. Schwaiger M, Brunken RC, Krivokapich J et al. (1987) Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J 8: 981–988PubMedGoogle Scholar
  60. Tillisch J, Brunken R, Marshall R et al. (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314: 884–888PubMedCrossRefGoogle Scholar
  61. Wagner HN, Burns HD, Dannals RF et al. (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 22: 1264–1266CrossRefGoogle Scholar
  62. Wilson RA, Shea MJ, De Landsheere CH et al. (1984) Validation of quantitation of regional myocardial blood flow in vivo with 11C-labeled human albumin microspheres and positron emission tomography. Circulation 70: 717–723PubMedCrossRefGoogle Scholar
  63. Wise R, Rhodes C, Gibbs J et al. (1983) The relationship between oxygen metabolism and glucose utilization in early cerebral infarcts. J Cereb Blood Flow Metab 3 (Suppl 1): S580–S581Google Scholar
  64. Wolf AP, Shiue CY, Fowler JS et al. (1987) The relationship between dopamine D-2 receptor occupancy by antipsychotic drugs and plasma drug levels as determined by 18F-N-methyl-spiroperidol (18F-NMS) and positron emission tomography (PET). J Cereb Blood Flow Metab 7: S361Google Scholar
  65. Wong DF, Wagner HN Jr, Dannals RF et al. (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226: 1393PubMedCrossRefGoogle Scholar
  66. Wong DF, Wagner HN Jr, Coyle J et al. (1985 a) Assessment of dopamine receptor blockade by neuroleptic drugs in the living human brain. J Nucl Med 26: 52Google Scholar
  67. Wong DF, Links J, Wagner HN Jr et al. (1985 b) Dopamine and serotonin receptors measured in vivo in Huntington’s disease with C-11 N-methylspiperone PET imaging (abstract). J Nucl Med 26: P107Google Scholar
  68. Wong DF, Gjedde A, Wagner HN Jr (1986a) Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands. J Cereb Blood Flow Metab 6:137–146PubMedCrossRefGoogle Scholar
  69. Wong DF, Gjedde A, Wagner HN Jr et al. (1986b) Quantification of neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity. J Cereb Blood Flow Metab 6: 147–153PubMedCrossRefGoogle Scholar
  70. Wong DF, Wagner HN Jr, Tune LE et al. (1986 c) Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558–1563CrossRefGoogle Scholar
  71. Wong DF, Lever JR, Hartig PR et al. (1987 a) Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using Nl-([11C]-Me)-2-Br-LSD. Synapse 1:393–398PubMedCrossRefGoogle Scholar
  72. Wong DF, Pearlson G, Tune LE et al. (1987 b) In vivo measurement of D2 dopamine receptor abnormalities in drug naive and treated manic-depressive patients. J Nucl Med 28:611Google Scholar
  73. Wong DF, Broussolle EP, Wand G et al. (1988 a) In vivo measurement of dopamine receptors in human brain by positron emission tomography: age and sex differences. In: Joseph JA (ed) Central determinants of age-related declines in motor function. Ann NY Acad Sci, New York, 203–214Google Scholar
  74. Wong DF, Solomon H, Natarajan TK et al. (1988 b) Cerebral blood flow, oxygen and glucose metabolism in jeopardized cerebrum after experimental stroke. J Nucl Med 29: 852–853Google Scholar
  75. Wong DF, Singer H, Pearlson G et al. (1988 c) D2 dopamine receptors in Tourette’s syndrome and manic depressive illness. J Nucl Med 29: 820Google Scholar
  76. Worley PF, Baraban JM, Snyder SH (1987) Beyond receptors: Multiple second-messenger systems in brain. Ann Neurol 21: 217–229PubMedCrossRefGoogle Scholar
  77. Yamamoto YL, Thompson CJ, Meyer E et al. (1977) Dynamic positron emission tomography for study of cerebral hemodynamics in a cross section of the head using positron-emitting 68Ga-EDTA and 77Kr. J Comput Assist Tomogr 1 : 43–55PubMedCrossRefGoogle Scholar
  78. Yen CK, Yano Y, Budinger TF et al. (1982) Brain tumor evaluation using Rb-82 and positron emission tomography. J Nucl Med 23: 532–537PubMedGoogle Scholar
  79. Young AB, Penney JB, Starosta-Rubinstein S et al. (1987) Normal caudate glucose metabolism in persons at risk for Huntington’s disease. Arch Neurol 44: 254PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Dean F. Wong
    • 1
  1. 1.Division of Nuclear Medicine, Dept. of Radiology and Radiological ScienceThe Johns Hopkins University, School of MedicineBaltimoreUSA

Personalised recommendations